American Testosterone Clinic for Men

Reading Time: < 1 minuteCOLUMBIA, Mo. (AP) -- A University of Missouri study has found that male testosterone levels during competition varies depending on relationships among the competitors - and may be related to the formation of alliances in war. The study, released Thursday, tracked men on the island of Dominica playing dominoes or cricket. It concluded that sporting events can bring camaraderie to a community and fuel rivalries, with testosterone levels rising or falling depending on who is involved. Anthropology professor Mark Flinn says testosterone levels increased during and after victories over strangers or rivals, but didn't change much when friends competed against … Read more »

Reading Time: 2 minutesRandy Dotinga HealthDay Reporter Posted: Friday, May 10, 2013, 2:44 PM FRIDAY, May 10 (HealthDay News) -- Testosterone supplements are touted as a cure for low libido, but men who take them may reduce their odds of fathering a child, new research suggests. Many men who sought infertility treatment at two U.S. clinics reported taking prescription testosterone supplements, according to a new study. And in most cases their sperm counts skyrocketed after they stopped taking the male hormone. The study, limited to a pair of clinics in Alabama and Kansas, looked at the years 2005 to 2011. The researchers don't … Read more »

Reading Time: < 1 minute(Reuters) - Reviewers for the U.S. Food and Drug Administration said safety data on Endo Health Solutions Inc's twice-rejected testosterone injection Aveed was "concerning" and showed that the therapy was associated with severe and immediate post-injection adverse events. No deaths were reported from the post-injection reactions, but resuscitations and hospitalizations were required in some cases, the reviewers said in documents posted on the FDA's website on Tuesday. (http://link.reuters.com/dem47t) "There are no known approaches to predict or prevent the occurrence of an Aveed-related severe post-injection reaction for any patient," the FDA reviewers said. "It is unclear whether a 'slowly administered' intramuscular … Read more »

Reading Time: 2 minutesBy Toni Clarke (Reuters) - An advisory panel to the U.S. Food and Drug Administration was sharply divided on Thursday over whether a drug made by Endo Health Solutions Inc can safely be prescribed for men with low testosterone. A panel of outside medical experts split 9-9, with some members saying the drug, Aveed, offers a valuable alternative to existing products, especially since it is already sold under the brand name Nebido outside the United States. Dr. William Cooper, professor of pediatrics and preventive medicine at Vanderbilt University School of Medicine, said he did not find anything in the data … Read more »

Reading Time: 2 minutesBy Matthew Perrone, The Associated Press WASHINGTON - Federal health experts issued a split opinion Thursday on whether a long-acting testosterone injection from Endo Health Solutions is safe. A Food and Drug Administration panel voted 9-9 on the safety of Endo's Aveed, a drug designed to be injected once every 10 weeks to boost testosterone in men with abnormally low levels. The FDA is not required to follow the group's advice, though it often does. Endo has asked the FDA to approve its drug as a long-term treatment for hypogonadism, or low testosterone caused by disease or damage to the … Read more »

Reading Time: 3 minutesA previous study by the University of Colorado Cancer Center reported the common side effect of low testosterone in men treated with the recently approved lung cancer agent, crizotinib. A new study published this week in the journal Cancer confirms this finding in a multi-national sample, details the mechanism of reduced testosterone, and provides promising preliminary evidence that widely available hormone replacement therapies can alleviate this side effect in many patients. Aurora, Colorado (PRWEB) April 19, 2013 "This was a wonderful collaboration between multiple centers confirming a side effect that had not been noted when the drug was initially approved … Read more »